Replies to post #613545 on NorthWest Biotherapeutics Inc (NWBO)

[pgsd]

Totally agree. What I "find Interesting and promising" is the use of ECA and as Abeta points out the first-ever Phase 3 trial in rGBM using an external control arm

[ilovetech]

eagle8 - To continue on your train of thought- It doesn't appear to be just coincidental to see DCVAX going through a list of regulatory checkpoints, as regulators are releasing new guidance by way of defining them. In other words, it's untenable to make up guidance from thin air. A model is preferable to reference in order to craft it in the first place. We have heard many times how the guidance seems to be tailor made for NWBO. However, it makes far more sense to say, "NWBO is tailor made for the guidance that is being crafted along the way. Assuming that's true, this type of collaboration would have the effect of moving things along slower, not faster. JMHO.

ILT